Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia
Weiqi Dang, Jingfang Xiao, Qinghua Ma, Jingya Miao, Mianfu Cao, Lu Chen, Yu Shi, Xiaohong Yao, Shichang Yu, Xindong Liu, You‐Hong Cui, Xia Zhang, Xiuwu Bian
Topics & Concepts
TemozolomideGliomaMicrogliaMedicineCancer researchImmunotherapyCombination therapyIntegrin alpha MImmunologyPharmacologyImmune systemInflammationGlioma Diagnosis and TreatmentImmune cells in cancerCancer Immunotherapy and Biomarkers